Empesertib (BAY1161909) is an experimental drug which acts as a selective inhibitor of the enzyme monopolar spindle 1 kinase (MPS1). It is in clinical trials for the treatment of breast cancer.
References
Wikipedia
Empesertib
Tags
- 4-Fluorophenyl compounds
- Anilides
- Anilines
- Experimental drugs
- Methoxy compounds
- Methylsulfonylbenzene derivatives
- Triazolopyridines